Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
No effect of topical digoxin and furosemide gel for patients with external anogenital warts.
Rijsbergen M, Rijneveld R, Todd M, Pagan L, Feiss G, de Koning MNC, van Alewijk DCJG, Klaassen ES, Burggraaf J, Rissmann R, van Poelgeest MIE. Rijsbergen M, et al. Among authors: rijneveld r. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e45-e46. doi: 10.1111/jdv.15894. Epub 2019 Sep 11. J Eur Acad Dermatol Venereol. 2020. PMID: 31430405 No abstract available.
Topical ionic contra-viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts.
van der Kolk T, Dillingh MR, Rijneveld R, Klaassen ES, de Koning MNC, Kouwenhoven STP, Genders RE, Bouwes Bavinck JN, Feiss G, Rissmann R, Burggraaf J. van der Kolk T, et al. Among authors: rijneveld r. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2088-2090. doi: 10.1111/jdv.14527. Epub 2017 Sep 6. J Eur Acad Dermatol Venereol. 2017. PMID: 28833595 Free PMC article.
Stereophotogrammetric three-dimensional photography is an accurate and precise planimetric method for the clinical visualization and quantification of human papilloma virus-induced skin lesions.
Rijsbergen M, Pagan L, Niemeyer-van der Kolk T, Rijneveld R, Hogendoorn G, Lemoine C, Meija Miranda Y, Feiss G, Bouwes Bavink JN, Burggraaf J, van Poelgeest MIE, Rissmann R. Rijsbergen M, et al. Among authors: rijneveld r. J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1506-1512. doi: 10.1111/jdv.15474. Epub 2019 Mar 12. J Eur Acad Dermatol Venereol. 2019. PMID: 30720900 Free PMC article.
Mobile e-diary application facilitates the monitoring of patient-reported outcomes and a high treatment adherence for clinical trials in dermatology.
Rijsbergen M, Niemeyer-van der Kolk T, Rijneveld R, Pinckaers JHFM, Meshcheriakov I, Bouwes Bavinck JN, van Doorn MBA, Hogendoorn G, Feiss G, Cohen AF, Burggraaf J, van Poelgeest MIE, Rissmann R. Rijsbergen M, et al. Among authors: rijneveld r. J Eur Acad Dermatol Venereol. 2020 Mar;34(3):633-639. doi: 10.1111/jdv.15872. Epub 2019 Sep 4. J Eur Acad Dermatol Venereol. 2020. PMID: 31419338 Free PMC article.
Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts.
Pagan L, Yfanti C, Rijneveld R, Todd M, Jongste P, Feijen JJ, Klaassen ES, Bouwes Bavinck JN, Struijk L, de Koning MNC, Prestegarden L, Niemeyer-van der Kolk T, van Poelgeest MIE, Rissmann R. Pagan L, et al. Among authors: rijneveld r. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e773-e775. doi: 10.1111/jdv.18291. Epub 2022 Jun 14. J Eur Acad Dermatol Venereol. 2022. PMID: 35699238 Clinical Trial. No abstract available.
Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions.
Rijsbergen M, Rijneveld R, Todd M, Feiss GL, Kouwenhoven STP, Quint KD, van Alewijk DCJG, de Koning MNC, Klaassen ES, Burggraaf J, Rissmann R, van Poelgeest MIE. Rijsbergen M, et al. Among authors: rijneveld r. Br J Clin Pharmacol. 2020 Nov;86(11):2133-2143. doi: 10.1111/bcp.14181. Epub 2020 Sep 28. Br J Clin Pharmacol. 2020. PMID: 31755993 Free PMC article. Clinical Trial.
Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial.
Niemeyer-van der Kolk T, van der Wall H, Hogendoorn GK, Rijneveld R, Luijten S, van Alewijk DCJG, van den Munckhof EHA, de Kam ML, Feiss GL, Prens EP, Burggraaf J, Rissmann R, van Doorn MBA. Niemeyer-van der Kolk T, et al. Among authors: rijneveld r. Clin Transl Sci. 2020 Sep;13(5):994-1003. doi: 10.1111/cts.12792. Epub 2020 May 1. Clin Transl Sci. 2020. PMID: 32315497 Free PMC article. Clinical Trial.
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug Development.
van der Kolk T, Assil S, Rijneveld R, Klaassen ES, Feiss G, Florencia E, Prens EP, Burggraaf J, Moerland M, Rissmann R, van Doorn MBA. van der Kolk T, et al. Among authors: rijneveld r. Clin Transl Sci. 2018 Nov;11(6):607-615. doi: 10.1111/cts.12563. Epub 2018 Jul 3. Clin Transl Sci. 2018. PMID: 29768709 Free PMC article. Clinical Trial.
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.
Balak DM, van Doorn MB, Arbeit RD, Rijneveld R, Klaassen E, Sullivan T, Brevard J, Thio HB, Prens EP, Burggraaf J, Rissmann R. Balak DM, et al. Among authors: rijneveld r. Clin Immunol. 2017 Jan;174:63-72. doi: 10.1016/j.clim.2016.09.015. Epub 2016 Nov 20. Clin Immunol. 2017. PMID: 27876460 Clinical Trial.